updateglenmark

Glenmark Pharmaceuticals shot up as much as 5 percent to touch a four-year high of Rs 546.60 on Wednesday on Morgan Stanley report. The foreign research firm Morgan Stanley has put an overweight rating on the stock due to strong earnings driven by growth in attractive markets like Brazil and...